Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Toulouse
The investigators will analyze if the tumor mobilization increases circulating DNA rate in peripheral and portal blood. Moreover, circulating tumor DNA will be measured during 12 months after surgery in peripheral blood. They will use a gene mutation detection technique called Next Generation Sequencing (NGS) which is more specific than a simple Polymerase Chain Reaction (PCR).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Every patient taken care by Toulouse University Hospital for the resection of a non-metastatic pancreatic adenocarcinoma by whipple resection.
Patient aged over 18 years old
Patient having given his written consent
Patient with social insurance coverage
You may not be if
Patients who had surgery, but their pathological examination of the resected specimen does not contain adenocarcinoma.
Patient for whom the surgery was not realized (exploratory laparotomy)
